Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens.
about
Making Bunyaviruses Talk: Interrogation Tactics to Identify Host Factors Required for InfectionThe New State of the Art: Cas9 for Gene Activation and RepressionAdvances in CRISPR-Cas9 genome engineering: lessons learned from RNA interferenceElectroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and TissuesContribution of high-content imaging technologies to the development of anti-infective drugsRAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?A Genome-Wide siRNA Screen Implicates Spire1/2 in SipA-Driven Salmonella Typhimurium Host Cell InvasionRNAi screening comes of age: improved techniques and complementary approachesmtDNA-Server: next-generation sequencing data analysis of human mitochondrial DNA in the cloudDetection of COPB2 as a KRAS synthetic lethal partner through integration of functional genomics screens.Genome-wide small interfering RNA screens reveal VAMP3 as a novel host factor required for Uukuniemi virus late penetrationChoosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.High-throughput functional genomics using CRISPR-Cas9.Morphological Profiles of RNAi-Induced Gene Knockdown Are Highly Reproducible but Dominated by Seed EffectsDeciphering Seed Sequence Based Off-Target Effects in a Large-Scale RNAi Reporter Screen for E-Cadherin ExpressiongespeR: a statistical model for deconvoluting off-target-confounded RNA interference screensThe siRNA Non-seed Region and Its Target Sequences Are Auxiliary Determinants of Off-Target Effects.Properties of short double-stranded RNAs carrying randomized base pairs: toward better controls for RNAi experimentsHigh-Throughput Small Interfering RNA Screening Identifies Phosphatidylinositol 3-Kinase Class II Alpha as Important for Production of Human Cytomegalovirus VirionsA novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation.Impact of RNA-guided technologies for target identification and deconvolution.Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products.Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.Stacking up CRISPR against RNAi for therapeutic gene inhibition.siPools: highly complex but accurately defined siRNA pools eliminate off-target effects.Off-targets in RNAi screens.[High-throughput small interfering RNA screens: when small interfering RNAs behave like microRNA].Importin α1 is required for nuclear import of herpes simplex virus proteins and capsid assembly in fibroblasts and neurons.Identifying HIPK1 as Target of miR-22-3p Enhancing Recombinant Protein Production From HEK 293 Cell by Using Microarray and HTP siRNA Screen.Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma.Growth-restricting effects of siRNA transfections: a largely deterministic combination of off-target binding and hybridization-independent competition
P2860
Q26748980-CF6628E8-5BD0-4094-9844-9B697A59EC55Q26787037-160E5293-71EE-40B1-85FD-965B9670FA49Q26852489-892768D6-5B1E-494E-80B6-C745607EC284Q26998879-C547FAAF-34D5-4321-9F0D-98AA4F87EEB2Q28079870-579A6655-D516-465E-85B7-F55DFD8DE1F3Q28260541-1C69431D-9B09-43ED-A3BE-115B409B2501Q28554073-BFCCAF54-B3FF-4426-8FD6-3541D8F79D9FQ28654521-8C786D78-6998-4185-A2AB-CE6D10A42279Q31078909-60FE60D6-D135-4248-B5B6-0AB6C9397F54Q33798340-E6D06F11-96CC-4102-8B8B-D3AD0E4272A6Q34057815-75B1170F-1340-4021-95E8-23C2F73A8A1CQ34477489-762B5D81-CF8B-4310-A215-0C49F10215C1Q35597703-6FB7ACD4-4DBF-45C9-87A7-1A2B1D158D69Q35702911-E4902BD1-2F6F-4523-9C38-E45168A7B1F7Q35771009-47703558-696D-4AAA-84DE-C3893B9CE0F5Q35800841-7343B262-28F4-44CB-87CD-7CEB6D725BD7Q35866632-80C3F443-4B3F-4E01-8C10-C83C938D0B38Q36286492-0A5D9BC5-4BF5-4841-A9F0-4078123055F6Q37224893-5F83252A-58B4-48DA-8550-57FB4D89A781Q37740931-68B76663-71DB-4117-932E-4AF549D211CCQ38243939-16E517F8-15A9-4965-AEDF-63975A49A18BQ38510631-5B707780-A805-4158-A2FA-91738BFDF457Q38676328-0E027EAE-CFEA-4FEE-96A3-680A913C3C82Q38811165-D71C3211-5E0F-45AF-8F3C-478FB609246DQ41980019-0B3FB3B7-86BD-49CF-AD5F-9B1DB345C939Q42219210-30F550AC-3899-421B-BA01-7493368F3928Q45023402-77F0E872-9BFE-4677-BF65-789A63EBDD4FQ47205447-7B9D644B-9DD0-45BA-AE2C-D74427DB1328Q47592940-D41DBE47-7848-4448-9C23-B12497F4C099Q55716930-2D850197-BC2A-48CB-88BD-9DB44369E5BDQ58744834-F7C62CD5-E7BD-49A7-8BDA-F5C5656FFBDE
P2860
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Specific inhibition of diverse ...... es inferred from RNAi screens.
@ast
Specific inhibition of diverse ...... es inferred from RNAi screens.
@en
type
label
Specific inhibition of diverse ...... es inferred from RNAi screens.
@ast
Specific inhibition of diverse ...... es inferred from RNAi screens.
@en
prefLabel
Specific inhibition of diverse ...... es inferred from RNAi screens.
@ast
Specific inhibition of diverse ...... es inferred from RNAi screens.
@en
P2093
P2860
P50
P356
P1476
Specific inhibition of diverse ...... es inferred from RNAi screens.
@en
P2093
Alain Casanova
Andrea Franceschini
Andreas Kaufmann
Ari Helenius
Daniel Andritschke
Lucas Pelkmans
Mario Emmenlauer
Pauli Rämö
Roger Meier
P2860
P304
P356
10.1073/PNAS.1402353111
P407
P577
2014-03-10T00:00:00Z